Company Overview

Update
Headquarters:
Westmount
IPO:
Went Public
Stock:
GUD
Categories:
Biotechnology
Description:
Knight Therapeutics Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing

Detailed Description

Update

Knight Therapeutics Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for the Canadian and world markets. Knight Therapeutics' shares began trading on the TSX-V on March 3, 2014 under the symbol GUD.

Current Team (2)

Update

Funding Rounds (1) - $180M

Update

Offices/Locations (1)

Update
  • Office

    376 Victoria Ave

    Suite #220, Quebec,

    Westmount, H3Z 1C3

    CAN

Images (1)

Update
  • D33057defed04ae4b1fcb8044ca4c772